| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dementia | 95 | 2025 | 488 | 16.720 |
Why?
|
| Depression | 69 | 2025 | 1362 | 9.470 |
Why?
|
| Caregivers | 37 | 2025 | 588 | 6.420 |
Why?
|
| Veterans | 62 | 2024 | 1785 | 5.920 |
Why?
|
| Depressive Disorder | 44 | 2022 | 484 | 5.350 |
Why?
|
| Anxiety Disorders | 52 | 2024 | 734 | 5.220 |
Why?
|
| Aggression | 23 | 2021 | 232 | 4.220 |
Why?
|
| Anxiety | 35 | 2024 | 1000 | 4.150 |
Why?
|
| Homebound Persons | 9 | 2020 | 17 | 3.900 |
Why?
|
| Aged | 212 | 2025 | 21768 | 3.540 |
Why?
|
| Pain | 18 | 2021 | 476 | 3.370 |
Why?
|
| Mental Health Services | 21 | 2024 | 278 | 3.320 |
Why?
|
| Independent Living | 11 | 2022 | 71 | 3.040 |
Why?
|
| Aged, 80 and over | 91 | 2025 | 7214 | 2.850 |
Why?
|
| Mental Disorders | 24 | 2022 | 887 | 2.470 |
Why?
|
| Alzheimer Disease | 20 | 2023 | 878 | 2.380 |
Why?
|
| Accidental Falls | 5 | 2021 | 120 | 2.300 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 17 | 2022 | 638 | 2.210 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 7 | 2022 | 103 | 1.900 |
Why?
|
| Nursing Homes | 7 | 2020 | 107 | 1.880 |
Why?
|
| Stress Disorders, Post-Traumatic | 15 | 2021 | 651 | 1.870 |
Why?
|
| Psychomotor Agitation | 16 | 2012 | 57 | 1.860 |
Why?
|
| Poverty | 11 | 2020 | 438 | 1.830 |
Why?
|
| Humans | 284 | 2025 | 134038 | 1.820 |
Why?
|
| United States Department of Veterans Affairs | 19 | 2024 | 710 | 1.810 |
Why?
|
| Male | 192 | 2025 | 66063 | 1.800 |
Why?
|
| Quality of Life | 29 | 2022 | 2160 | 1.740 |
Why?
|
| Middle Aged | 119 | 2025 | 29389 | 1.690 |
Why?
|
| Female | 176 | 2025 | 71861 | 1.650 |
Why?
|
| Psychotherapy | 7 | 2022 | 246 | 1.630 |
Why?
|
| Telemedicine | 10 | 2021 | 503 | 1.580 |
Why?
|
| Psychiatric Status Rating Scales | 41 | 2020 | 854 | 1.570 |
Why?
|
| Diabetes Mellitus, Type 2 | 6 | 2024 | 1416 | 1.430 |
Why?
|
| Hospitals, Veterans | 15 | 2024 | 364 | 1.400 |
Why?
|
| United States | 50 | 2025 | 11760 | 1.390 |
Why?
|
| Psychotherapy, Brief | 5 | 2019 | 57 | 1.340 |
Why?
|
| Activities of Daily Living | 21 | 2022 | 432 | 1.330 |
Why?
|
| Cooperative Behavior | 5 | 2015 | 233 | 1.260 |
Why?
|
| Patient Acceptance of Health Care | 6 | 2019 | 475 | 1.220 |
Why?
|
| Geriatric Assessment | 20 | 2020 | 188 | 1.200 |
Why?
|
| Mental Health | 11 | 2023 | 373 | 1.180 |
Why?
|
| Primary Health Care | 21 | 2020 | 803 | 1.180 |
Why?
|
| Needs Assessment | 3 | 2024 | 182 | 1.140 |
Why?
|
| Pain Management | 5 | 2017 | 199 | 1.120 |
Why?
|
| Aging | 8 | 2022 | 1306 | 1.090 |
Why?
|
| Antipsychotic Agents | 15 | 2022 | 389 | 1.080 |
Why?
|
| Comorbidity | 32 | 2020 | 1625 | 1.070 |
Why?
|
| Emergency Service, Hospital | 5 | 2024 | 1155 | 1.060 |
Why?
|
| Delivery of Health Care | 5 | 2017 | 680 | 1.040 |
Why?
|
| Adaptation, Psychological | 14 | 2023 | 449 | 1.030 |
Why?
|
| Patient Care Team | 10 | 2019 | 574 | 0.980 |
Why?
|
| Parkinson Disease | 8 | 2020 | 740 | 0.960 |
Why?
|
| Analgesics | 2 | 2017 | 133 | 0.940 |
Why?
|
| Qualitative Research | 6 | 2024 | 639 | 0.930 |
Why?
|
| Age Factors | 18 | 2019 | 2997 | 0.930 |
Why?
|
| Health Services for the Aged | 5 | 2016 | 40 | 0.920 |
Why?
|
| Delivery of Health Care, Integrated | 5 | 2024 | 138 | 0.880 |
Why?
|
| Health Surveys | 3 | 2019 | 262 | 0.880 |
Why?
|
| Treatment Outcome | 42 | 2022 | 13073 | 0.870 |
Why?
|
| Cross-Sectional Studies | 17 | 2024 | 3754 | 0.840 |
Why?
|
| Bipolar Disorder | 7 | 2019 | 367 | 0.840 |
Why?
|
| Cognitive Dysfunction | 4 | 2022 | 314 | 0.820 |
Why?
|
| Severity of Illness Index | 28 | 2018 | 3113 | 0.810 |
Why?
|
| Randomized Controlled Trials as Topic | 11 | 2022 | 1217 | 0.800 |
Why?
|
| Psychometrics | 14 | 2021 | 689 | 0.800 |
Why?
|
| Pain Measurement | 8 | 2017 | 370 | 0.800 |
Why?
|
| Stress, Psychological | 6 | 2019 | 603 | 0.800 |
Why?
|
| Texas | 21 | 2024 | 3715 | 0.770 |
Why?
|
| Long-Term Care | 3 | 2018 | 73 | 0.750 |
Why?
|
| Community Mental Health Services | 5 | 2016 | 41 | 0.750 |
Why?
|
| Interviews as Topic | 11 | 2024 | 421 | 0.740 |
Why?
|
| Surveys and Questionnaires | 27 | 2021 | 3999 | 0.720 |
Why?
|
| Medically Underserved Area | 3 | 2018 | 94 | 0.710 |
Why?
|
| Comprehensive Health Care | 2 | 2019 | 19 | 0.700 |
Why?
|
| Patient Care Planning | 4 | 2019 | 133 | 0.690 |
Why?
|
| Psychotic Disorders | 7 | 2010 | 149 | 0.690 |
Why?
|
| C-Reactive Protein | 1 | 2023 | 471 | 0.690 |
Why?
|
| Central Nervous System Agents | 1 | 2020 | 16 | 0.670 |
Why?
|
| Referral and Consultation | 5 | 2019 | 574 | 0.670 |
Why?
|
| Hospitalization | 19 | 2024 | 1906 | 0.670 |
Why?
|
| Telephone | 10 | 2019 | 127 | 0.670 |
Why?
|
| Health Behavior | 2 | 2023 | 404 | 0.660 |
Why?
|
| Family | 5 | 2024 | 589 | 0.660 |
Why?
|
| Cognition Disorders | 11 | 2011 | 579 | 0.660 |
Why?
|
| Polypharmacy | 1 | 2020 | 40 | 0.660 |
Why?
|
| Schizophrenia | 7 | 2019 | 332 | 0.650 |
Why?
|
| Longitudinal Studies | 13 | 2019 | 1506 | 0.650 |
Why?
|
| Ambulatory Care | 6 | 2016 | 414 | 0.640 |
Why?
|
| Health Services Needs and Demand | 3 | 2016 | 179 | 0.640 |
Why?
|
| Health Services Misuse | 3 | 2017 | 28 | 0.640 |
Why?
|
| Hypnotics and Sedatives | 3 | 2016 | 138 | 0.630 |
Why?
|
| Patient Satisfaction | 8 | 2016 | 490 | 0.630 |
Why?
|
| Antidepressive Agents | 6 | 2016 | 326 | 0.620 |
Why?
|
| Healthy Lifestyle | 1 | 2019 | 31 | 0.620 |
Why?
|
| Personality Assessment | 6 | 2009 | 110 | 0.620 |
Why?
|
| Social Participation | 1 | 2019 | 12 | 0.620 |
Why?
|
| Fear | 3 | 2021 | 205 | 0.610 |
Why?
|
| Cholinesterase Inhibitors | 2 | 2017 | 102 | 0.610 |
Why?
|
| Counseling | 2 | 2018 | 241 | 0.610 |
Why?
|
| Community-Institutional Relations | 2 | 2018 | 36 | 0.610 |
Why?
|
| Continuity of Patient Care | 2 | 2011 | 153 | 0.600 |
Why?
|
| Length of Stay | 6 | 2018 | 1391 | 0.600 |
Why?
|
| Health Personnel | 4 | 2024 | 541 | 0.600 |
Why?
|
| Somatoform Disorders | 3 | 2009 | 46 | 0.600 |
Why?
|
| Feasibility Studies | 9 | 2023 | 827 | 0.590 |
Why?
|
| Respiratory Tract Diseases | 1 | 2019 | 81 | 0.590 |
Why?
|
| Spirituality | 4 | 2018 | 52 | 0.580 |
Why?
|
| Self Report | 9 | 2022 | 553 | 0.580 |
Why?
|
| Evidence-Based Medicine | 7 | 2016 | 682 | 0.580 |
Why?
|
| Therapeutic Touch | 1 | 2017 | 1 | 0.570 |
Why?
|
| Psychiatric Department, Hospital | 5 | 2010 | 23 | 0.570 |
Why?
|
| Deprescriptions | 1 | 2017 | 12 | 0.560 |
Why?
|
| Cognition | 10 | 2022 | 816 | 0.550 |
Why?
|
| Empathy | 1 | 2017 | 63 | 0.540 |
Why?
|
| Prevalence | 16 | 2024 | 2684 | 0.540 |
Why?
|
| Pleasure | 1 | 2017 | 12 | 0.540 |
Why?
|
| Cultural Competency | 1 | 2018 | 52 | 0.540 |
Why?
|
| Adult | 36 | 2024 | 31921 | 0.530 |
Why?
|
| Depressive Disorder, Major | 4 | 2018 | 473 | 0.530 |
Why?
|
| Costs and Cost Analysis | 3 | 2015 | 165 | 0.520 |
Why?
|
| Heart Failure | 9 | 2019 | 2437 | 0.510 |
Why?
|
| Medication Adherence | 1 | 2019 | 343 | 0.500 |
Why?
|
| Behavior Therapy | 3 | 2021 | 268 | 0.500 |
Why?
|
| Minority Groups | 3 | 2018 | 256 | 0.490 |
Why?
|
| Social Isolation | 3 | 2013 | 48 | 0.490 |
Why?
|
| Professional Competence | 2 | 2014 | 98 | 0.480 |
Why?
|
| Students, Medical | 2 | 2018 | 363 | 0.470 |
Why?
|
| Neuropsychological Tests | 19 | 2022 | 989 | 0.470 |
Why?
|
| Interdisciplinary Communication | 2 | 2013 | 135 | 0.470 |
Why?
|
| Social Behavior | 1 | 2017 | 230 | 0.460 |
Why?
|
| Drug Prescriptions | 1 | 2016 | 240 | 0.460 |
Why?
|
| Frailty | 4 | 2022 | 132 | 0.460 |
Why?
|
| Stroke | 3 | 2014 | 1077 | 0.460 |
Why?
|
| Sleep Wake Disorders | 2 | 2021 | 187 | 0.460 |
Why?
|
| Urban Population | 2 | 2014 | 243 | 0.450 |
Why?
|
| Health Promotion | 1 | 2018 | 405 | 0.440 |
Why?
|
| Practice Guidelines as Topic | 4 | 2017 | 1340 | 0.430 |
Why?
|
| Community Health Services | 2 | 2013 | 93 | 0.430 |
Why?
|
| Frail Elderly | 6 | 2022 | 107 | 0.430 |
Why?
|
| Risk Factors | 18 | 2019 | 11179 | 0.420 |
Why?
|
| Diabetes Mellitus | 5 | 2021 | 937 | 0.420 |
Why?
|
| Disability Evaluation | 5 | 2018 | 195 | 0.420 |
Why?
|
| Health Knowledge, Attitudes, Practice | 4 | 2024 | 905 | 0.420 |
Why?
|
| Friends | 1 | 2013 | 16 | 0.420 |
Why?
|
| Motor Activity | 4 | 2020 | 531 | 0.420 |
Why?
|
| Geriatrics | 6 | 2016 | 78 | 0.420 |
Why?
|
| Health Services Research | 4 | 2014 | 190 | 0.410 |
Why?
|
| Postpartum Period | 1 | 2014 | 229 | 0.400 |
Why?
|
| Exercise | 1 | 2019 | 869 | 0.400 |
Why?
|
| Incidence | 10 | 2020 | 3416 | 0.400 |
Why?
|
| Benzodiazepines | 5 | 2022 | 112 | 0.400 |
Why?
|
| Chronic Pain | 1 | 2015 | 149 | 0.400 |
Why?
|
| Technology | 1 | 2013 | 71 | 0.400 |
Why?
|
| Interpersonal Relations | 3 | 2012 | 229 | 0.390 |
Why?
|
| Patient Care Management | 2 | 2016 | 68 | 0.390 |
Why?
|
| Obesity | 2 | 2023 | 2446 | 0.390 |
Why?
|
| Reproducibility of Results | 20 | 2021 | 3043 | 0.380 |
Why?
|
| Attitude to Death | 2 | 2009 | 39 | 0.380 |
Why?
|
| Program Development | 4 | 2012 | 190 | 0.380 |
Why?
|
| Health Services | 4 | 2012 | 73 | 0.380 |
Why?
|
| Health Care Costs | 2 | 2015 | 407 | 0.380 |
Why?
|
| Irritable Mood | 1 | 2011 | 11 | 0.380 |
Why?
|
| Mass Screening | 8 | 2024 | 840 | 0.370 |
Why?
|
| Hypertension | 3 | 2012 | 1396 | 0.370 |
Why?
|
| Sick Role | 3 | 2009 | 32 | 0.370 |
Why?
|
| Personality Inventory | 5 | 2013 | 176 | 0.370 |
Why?
|
| Wounds and Injuries | 3 | 2019 | 394 | 0.370 |
Why?
|
| Mental Competency | 8 | 2009 | 53 | 0.360 |
Why?
|
| Financing, Personal | 1 | 2011 | 10 | 0.350 |
Why?
|
| Self-Assessment | 3 | 2009 | 65 | 0.350 |
Why?
|
| Religion | 3 | 2018 | 51 | 0.350 |
Why?
|
| Information Dissemination | 1 | 2013 | 198 | 0.350 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2019 | 807 | 0.340 |
Why?
|
| Predictive Value of Tests | 7 | 2015 | 2301 | 0.340 |
Why?
|
| Antihypertensive Agents | 2 | 2012 | 409 | 0.330 |
Why?
|
| Personality Disorders | 4 | 2009 | 162 | 0.330 |
Why?
|
| Spouses | 1 | 2011 | 71 | 0.330 |
Why?
|
| Self Concept | 3 | 2005 | 163 | 0.330 |
Why?
|
| Patients | 1 | 2011 | 127 | 0.320 |
Why?
|
| Academic Medical Centers | 2 | 2010 | 332 | 0.320 |
Why?
|
| Health Services Accessibility | 6 | 2024 | 649 | 0.320 |
Why?
|
| Socioeconomic Factors | 7 | 2016 | 920 | 0.320 |
Why?
|
| Hospitalists | 1 | 2010 | 46 | 0.320 |
Why?
|
| Religion and Medicine | 1 | 2009 | 25 | 0.320 |
Why?
|
| Pilot Projects | 10 | 2020 | 1492 | 0.320 |
Why?
|
| Military Personnel | 2 | 2016 | 204 | 0.310 |
Why?
|
| Coronary Disease | 2 | 2013 | 721 | 0.310 |
Why?
|
| Remote Consultation | 1 | 2009 | 25 | 0.310 |
Why?
|
| Diagnostic Errors | 3 | 2020 | 347 | 0.300 |
Why?
|
| Attitude of Health Personnel | 2 | 2024 | 718 | 0.300 |
Why?
|
| Phototherapy | 1 | 2009 | 39 | 0.300 |
Why?
|
| Chronic Disease | 6 | 2019 | 1249 | 0.300 |
Why?
|
| Personal Autonomy | 4 | 2009 | 202 | 0.300 |
Why?
|
| Valproic Acid | 4 | 2017 | 168 | 0.300 |
Why?
|
| Arthritis | 1 | 2009 | 86 | 0.290 |
Why?
|
| Hepatitis C, Chronic | 3 | 2007 | 373 | 0.290 |
Why?
|
| Follow-Up Studies | 10 | 2017 | 5477 | 0.290 |
Why?
|
| Research Design | 3 | 2012 | 747 | 0.290 |
Why?
|
| Wearable Electronic Devices | 5 | 2021 | 107 | 0.290 |
Why?
|
| Patient Education as Topic | 2 | 2011 | 469 | 0.290 |
Why?
|
| Retrospective Studies | 27 | 2022 | 17535 | 0.280 |
Why?
|
| Logistic Models | 6 | 2019 | 1909 | 0.280 |
Why?
|
| Decision Making | 9 | 2013 | 700 | 0.280 |
Why?
|
| Psychiatry | 3 | 2010 | 271 | 0.270 |
Why?
|
| Antiviral Agents | 4 | 2007 | 824 | 0.270 |
Why?
|
| Patient Compliance | 6 | 2014 | 481 | 0.270 |
Why?
|
| Antidepressive Agents, Tricyclic | 2 | 2022 | 26 | 0.270 |
Why?
|
| Models, Organizational | 2 | 2019 | 44 | 0.270 |
Why?
|
| Self Efficacy | 4 | 2018 | 207 | 0.270 |
Why?
|
| Social Support | 7 | 2015 | 384 | 0.260 |
Why?
|
| Delirium | 3 | 2013 | 60 | 0.260 |
Why?
|
| Career Choice | 1 | 2008 | 163 | 0.260 |
Why?
|
| Mentors | 1 | 2008 | 160 | 0.260 |
Why?
|
| Geriatric Psychiatry | 7 | 2004 | 12 | 0.250 |
Why?
|
| Alcoholism | 3 | 2007 | 253 | 0.250 |
Why?
|
| Professional-Patient Relations | 3 | 2014 | 92 | 0.250 |
Why?
|
| Sex Factors | 4 | 2023 | 1387 | 0.250 |
Why?
|
| Palliative Care | 2 | 2009 | 463 | 0.250 |
Why?
|
| Interferon-alpha | 1 | 2007 | 248 | 0.250 |
Why?
|
| Rehabilitation | 1 | 2005 | 23 | 0.250 |
Why?
|
| Documentation | 1 | 2007 | 122 | 0.250 |
Why?
|
| Health Status | 6 | 2012 | 412 | 0.240 |
Why?
|
| Risperidone | 4 | 2017 | 60 | 0.240 |
Why?
|
| Cohort Studies | 11 | 2018 | 5213 | 0.240 |
Why?
|
| Nursing Staff | 1 | 2005 | 15 | 0.240 |
Why?
|
| Proportional Hazards Models | 3 | 2020 | 1488 | 0.240 |
Why?
|
| Respiration Disorders | 1 | 2005 | 32 | 0.230 |
Why?
|
| Emergency Services, Psychiatric | 1 | 2005 | 23 | 0.230 |
Why?
|
| Utilization Review | 4 | 2011 | 41 | 0.230 |
Why?
|
| Psychotropic Drugs | 3 | 2019 | 130 | 0.230 |
Why?
|
| Fellowships and Scholarships | 1 | 2008 | 314 | 0.230 |
Why?
|
| Inpatients | 6 | 2013 | 547 | 0.220 |
Why?
|
| Vulnerable Populations | 4 | 2016 | 148 | 0.220 |
Why?
|
| Lung Diseases, Obstructive | 2 | 2001 | 34 | 0.220 |
Why?
|
| Clinical Trials as Topic | 3 | 2021 | 1157 | 0.220 |
Why?
|
| Quality of Health Care | 1 | 2007 | 420 | 0.220 |
Why?
|
| Professional Role | 1 | 2024 | 72 | 0.220 |
Why?
|
| Self Care | 4 | 2009 | 225 | 0.210 |
Why?
|
| Diabetes Complications | 2 | 2019 | 206 | 0.210 |
Why?
|
| Databases, Factual | 5 | 2016 | 1258 | 0.210 |
Why?
|
| Alcohol Drinking | 2 | 2019 | 387 | 0.210 |
Why?
|
| Tobacco Use Cessation | 1 | 2023 | 5 | 0.210 |
Why?
|
| Patient Discharge | 4 | 2010 | 519 | 0.210 |
Why?
|
| Clinical Competence | 2 | 2024 | 1062 | 0.210 |
Why?
|
| Mental Status Schedule | 7 | 2007 | 45 | 0.210 |
Why?
|
| Testosterone | 3 | 2005 | 623 | 0.210 |
Why?
|
| Program Evaluation | 5 | 2017 | 457 | 0.210 |
Why?
|
| Recovery of Function | 1 | 2005 | 464 | 0.210 |
Why?
|
| Body Weight Maintenance | 1 | 2023 | 4 | 0.210 |
Why?
|
| Prospective Studies | 11 | 2020 | 6601 | 0.200 |
Why?
|
| Dementia, Vascular | 3 | 2010 | 17 | 0.200 |
Why?
|
| Religion and Psychology | 3 | 2014 | 33 | 0.200 |
Why?
|
| Androgens | 1 | 2005 | 300 | 0.200 |
Why?
|
| Counselors | 1 | 2022 | 24 | 0.190 |
Why?
|
| Serotonin and Noradrenaline Reuptake Inhibitors | 1 | 2022 | 13 | 0.190 |
Why?
|
| Young Adult | 4 | 2019 | 9928 | 0.190 |
Why?
|
| Smoking Cessation | 1 | 2023 | 209 | 0.180 |
Why?
|
| REM Sleep Behavior Disorder | 1 | 2021 | 17 | 0.180 |
Why?
|
| Freedom | 2 | 2000 | 18 | 0.180 |
Why?
|
| Patient-Centered Care | 2 | 2017 | 236 | 0.180 |
Why?
|
| Walking Speed | 1 | 2021 | 18 | 0.180 |
Why?
|
| Diagnosis, Differential | 7 | 2019 | 1978 | 0.180 |
Why?
|
| Awareness | 3 | 2005 | 80 | 0.170 |
Why?
|
| Pandemics | 3 | 2023 | 1190 | 0.170 |
Why?
|
| Problem Behavior | 1 | 2021 | 41 | 0.170 |
Why?
|
| Community Health Workers | 2 | 2024 | 76 | 0.170 |
Why?
|
| Social Media | 1 | 2022 | 120 | 0.170 |
Why?
|
| Mood Disorders | 4 | 2014 | 130 | 0.170 |
Why?
|
| Object Attachment | 1 | 2001 | 52 | 0.170 |
Why?
|
| Social Behavior Disorders | 1 | 2000 | 12 | 0.160 |
Why?
|
| Accelerometry | 1 | 2020 | 64 | 0.160 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2021 | 137 | 0.160 |
Why?
|
| Advance Directives | 1 | 2020 | 33 | 0.160 |
Why?
|
| Dizziness | 1 | 2019 | 29 | 0.160 |
Why?
|
| Suicidal Ideation | 2 | 2021 | 252 | 0.160 |
Why?
|
| Current Procedural Terminology | 1 | 2019 | 5 | 0.160 |
Why?
|
| Cerebrovascular Disorders | 1 | 2019 | 124 | 0.150 |
Why?
|
| Medicare | 1 | 2022 | 465 | 0.150 |
Why?
|
| Electroconvulsive Therapy | 2 | 2018 | 82 | 0.150 |
Why?
|
| Neurobehavioral Manifestations | 1 | 1998 | 1 | 0.150 |
Why?
|
| Reference Standards | 3 | 2013 | 247 | 0.150 |
Why?
|
| Combined Modality Therapy | 6 | 2023 | 1310 | 0.150 |
Why?
|
| Regression Analysis | 5 | 2018 | 827 | 0.150 |
Why?
|
| Physicians | 1 | 2005 | 639 | 0.140 |
Why?
|
| Medical Records Systems, Computerized | 2 | 2013 | 172 | 0.140 |
Why?
|
| Treatment Failure | 1 | 2019 | 367 | 0.140 |
Why?
|
| Behavioral Symptoms | 1 | 1998 | 26 | 0.140 |
Why?
|
| Case-Control Studies | 8 | 2020 | 3666 | 0.140 |
Why?
|
| GABA Agents | 1 | 1998 | 20 | 0.140 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 3 | 2024 | 228 | 0.140 |
Why?
|
| Psychomotor Performance | 2 | 2009 | 182 | 0.140 |
Why?
|
| Paternalism | 1 | 1997 | 30 | 0.140 |
Why?
|
| Lithium Carbonate | 1 | 2017 | 21 | 0.140 |
Why?
|
| Walking | 3 | 2021 | 233 | 0.140 |
Why?
|
| Internship and Residency | 1 | 2008 | 1250 | 0.140 |
Why?
|
| Internal-External Control | 2 | 2017 | 75 | 0.140 |
Why?
|
| Electronic Health Records | 3 | 2020 | 797 | 0.140 |
Why?
|
| Antimanic Agents | 1 | 2017 | 37 | 0.140 |
Why?
|
| Fractures, Bone | 1 | 2019 | 211 | 0.140 |
Why?
|
| Transcranial Direct Current Stimulation | 1 | 2017 | 21 | 0.140 |
Why?
|
| Education | 1 | 2017 | 111 | 0.140 |
Why?
|
| Body Mass Index | 1 | 2023 | 1718 | 0.130 |
Why?
|
| Hospitals, Psychiatric | 2 | 1997 | 68 | 0.130 |
Why?
|
| Psychotherapy, Group | 2 | 2007 | 59 | 0.130 |
Why?
|
| Trail Making Test | 1 | 2016 | 6 | 0.130 |
Why?
|
| Geriatric Nursing | 1 | 2016 | 4 | 0.130 |
Why?
|
| Patient Care | 1 | 1997 | 100 | 0.130 |
Why?
|
| Rural Population | 2 | 2016 | 280 | 0.130 |
Why?
|
| Biomarkers | 2 | 2023 | 3434 | 0.130 |
Why?
|
| Motor Cortex | 1 | 2017 | 85 | 0.130 |
Why?
|
| Licensure | 1 | 2016 | 15 | 0.130 |
Why?
|
| Culturally Competent Care | 1 | 2017 | 51 | 0.130 |
Why?
|
| Cost of Illness | 2 | 2010 | 277 | 0.130 |
Why?
|
| Time Factors | 5 | 2014 | 6610 | 0.130 |
Why?
|
| Myocardial Ischemia | 1 | 2019 | 365 | 0.120 |
Why?
|
| Brain Injuries, Traumatic | 1 | 2020 | 300 | 0.120 |
Why?
|
| Healthcare Disparities | 2 | 2018 | 481 | 0.120 |
Why?
|
| Education, Distance | 1 | 2016 | 66 | 0.120 |
Why?
|
| Outpatients | 4 | 2018 | 276 | 0.120 |
Why?
|
| Health Care Surveys | 1 | 2016 | 294 | 0.120 |
Why?
|
| Substance-Related Disorders | 4 | 2005 | 492 | 0.120 |
Why?
|
| Emergency Medical Services | 1 | 2019 | 414 | 0.120 |
Why?
|
| Adolescent | 5 | 2016 | 20603 | 0.120 |
Why?
|
| Analgesics, Opioid | 1 | 2020 | 464 | 0.120 |
Why?
|
| Patient Protection and Affordable Care Act | 1 | 2016 | 66 | 0.120 |
Why?
|
| Observer Variation | 3 | 2005 | 314 | 0.120 |
Why?
|
| Models, Statistical | 3 | 2015 | 505 | 0.120 |
Why?
|
| Patient Readmission | 3 | 2013 | 429 | 0.110 |
Why?
|
| Clomipramine | 1 | 1994 | 16 | 0.110 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2015 | 138 | 0.110 |
Why?
|
| Elder Abuse | 2 | 2012 | 25 | 0.110 |
Why?
|
| Home Care Services | 2 | 2016 | 81 | 0.110 |
Why?
|
| Hospitals | 1 | 1997 | 437 | 0.110 |
Why?
|
| Interoception | 1 | 2014 | 8 | 0.110 |
Why?
|
| Anti-Anxiety Agents | 3 | 2010 | 77 | 0.110 |
Why?
|
| Social Environment | 2 | 2010 | 126 | 0.110 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2015 | 226 | 0.110 |
Why?
|
| Cost-Benefit Analysis | 3 | 2022 | 563 | 0.110 |
Why?
|
| Advisory Committees | 1 | 2014 | 158 | 0.110 |
Why?
|
| Panic Disorder | 1 | 2014 | 52 | 0.110 |
Why?
|
| Problem Solving | 1 | 2014 | 67 | 0.110 |
Why?
|
| Models, Nursing | 1 | 2013 | 8 | 0.110 |
Why?
|
| Osteoarthritis, Knee | 1 | 2017 | 272 | 0.110 |
Why?
|
| Risk | 4 | 2020 | 836 | 0.100 |
Why?
|
| Smoking | 1 | 2019 | 1136 | 0.100 |
Why?
|
| Risk Assessment | 2 | 2022 | 3742 | 0.100 |
Why?
|
| Patient Selection | 4 | 2019 | 735 | 0.100 |
Why?
|
| Patient Admission | 5 | 2008 | 190 | 0.100 |
Why?
|
| Dreams | 1 | 2013 | 23 | 0.100 |
Why?
|
| Quality Improvement | 1 | 2019 | 700 | 0.100 |
Why?
|
| Dyslipidemias | 1 | 2015 | 245 | 0.100 |
Why?
|
| Legal Guardians | 3 | 2009 | 12 | 0.100 |
Why?
|
| Personality | 1 | 2013 | 115 | 0.100 |
Why?
|
| Public-Private Sector Partnerships | 1 | 2012 | 18 | 0.100 |
Why?
|
| Theft | 1 | 2012 | 5 | 0.100 |
Why?
|
| Psychology | 2 | 2010 | 62 | 0.090 |
Why?
|
| Fraud | 1 | 2012 | 18 | 0.090 |
Why?
|
| Investments | 1 | 2012 | 12 | 0.090 |
Why?
|
| Drug Utilization | 1 | 2013 | 170 | 0.090 |
Why?
|
| Emotions | 2 | 2005 | 364 | 0.090 |
Why?
|
| Drug Therapy, Combination | 3 | 2017 | 1200 | 0.090 |
Why?
|
| Social Welfare | 1 | 2011 | 6 | 0.090 |
Why?
|
| Antineoplastic Agents | 1 | 2021 | 1853 | 0.090 |
Why?
|
| Job Satisfaction | 1 | 2012 | 93 | 0.090 |
Why?
|
| Physicians, Women | 1 | 2012 | 52 | 0.090 |
Why?
|
| Placebos | 2 | 2017 | 240 | 0.090 |
Why?
|
| Societies | 1 | 2011 | 27 | 0.090 |
Why?
|
| Financial Management | 1 | 2011 | 15 | 0.090 |
Why?
|
| Proxy | 1 | 2011 | 21 | 0.090 |
Why?
|
| Statistics as Topic | 3 | 2007 | 261 | 0.090 |
Why?
|
| Education, Medical, Continuing | 1 | 2012 | 145 | 0.090 |
Why?
|
| Focus Groups | 2 | 2010 | 212 | 0.090 |
Why?
|
| Advance Care Planning | 1 | 2011 | 41 | 0.080 |
Why?
|
| Informed Consent | 3 | 2009 | 345 | 0.080 |
Why?
|
| Factor Analysis, Statistical | 2 | 2014 | 233 | 0.080 |
Why?
|
| Gait | 2 | 2021 | 141 | 0.080 |
Why?
|
| Narcissism | 1 | 2009 | 7 | 0.080 |
Why?
|
| Medical Records | 1 | 2011 | 194 | 0.080 |
Why?
|
| Ambulatory Care Facilities | 2 | 2023 | 241 | 0.080 |
Why?
|
| Urban Health Services | 1 | 2010 | 22 | 0.080 |
Why?
|
| Drug Tolerance | 4 | 1999 | 40 | 0.080 |
Why?
|
| Rural Health Services | 1 | 2010 | 28 | 0.080 |
Why?
|
| Mind-Body Therapies | 1 | 2009 | 12 | 0.080 |
Why?
|
| Hepatitis C | 2 | 2005 | 389 | 0.080 |
Why?
|
| Family Relations | 1 | 2010 | 71 | 0.080 |
Why?
|
| Attitude to Health | 2 | 2009 | 264 | 0.080 |
Why?
|
| Patient Participation | 2 | 2009 | 239 | 0.080 |
Why?
|
| Self-Help Groups | 1 | 2009 | 17 | 0.080 |
Why?
|
| Mianserin | 1 | 2009 | 3 | 0.080 |
Why?
|
| Disease Progression | 4 | 2010 | 2266 | 0.080 |
Why?
|
| Specialization | 1 | 2010 | 82 | 0.080 |
Why?
|
| Models, Psychological | 1 | 2010 | 145 | 0.080 |
Why?
|
| Veterans Health | 1 | 2010 | 179 | 0.080 |
Why?
|
| Sleep | 3 | 2021 | 370 | 0.080 |
Why?
|
| Aftercare | 1 | 2010 | 156 | 0.080 |
Why?
|
| Survival Analysis | 1 | 2012 | 1599 | 0.070 |
Why?
|
| Task Performance and Analysis | 3 | 2018 | 91 | 0.070 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2015 | 757 | 0.070 |
Why?
|
| Southeastern United States | 1 | 2008 | 40 | 0.070 |
Why?
|
| Sensitivity and Specificity | 3 | 2013 | 2172 | 0.070 |
Why?
|
| Life Support Care | 1 | 2008 | 47 | 0.070 |
Why?
|
| Terminally Ill | 1 | 2008 | 29 | 0.070 |
Why?
|
| Psychological Tests | 2 | 2005 | 94 | 0.070 |
Why?
|
| Delayed Diagnosis | 1 | 2009 | 135 | 0.070 |
Why?
|
| Phobic Disorders | 1 | 2008 | 43 | 0.070 |
Why?
|
| Neurocognitive Disorders | 4 | 1997 | 77 | 0.070 |
Why?
|
| Pyridines | 1 | 2009 | 250 | 0.070 |
Why?
|
| Family Practice | 1 | 2007 | 92 | 0.070 |
Why?
|
| Prejudice | 1 | 2007 | 39 | 0.070 |
Why?
|
| Hippocampus | 1 | 2013 | 863 | 0.070 |
Why?
|
| Circadian Rhythm | 1 | 2009 | 298 | 0.060 |
Why?
|
| Prognosis | 6 | 2014 | 5084 | 0.060 |
Why?
|
| Hostility | 2 | 2013 | 21 | 0.060 |
Why?
|
| Memory, Short-Term | 1 | 2007 | 149 | 0.060 |
Why?
|
| Neoplasms | 1 | 2021 | 3037 | 0.060 |
Why?
|
| Comprehension | 3 | 2009 | 81 | 0.060 |
Why?
|
| Community-Based Participatory Research | 2 | 2017 | 54 | 0.060 |
Why?
|
| Interview, Psychological | 2 | 2019 | 107 | 0.060 |
Why?
|
| Cardiovascular Diseases | 1 | 2018 | 2090 | 0.060 |
Why?
|
| Stroke Rehabilitation | 1 | 2005 | 70 | 0.060 |
Why?
|
| Sickness Impact Profile | 1 | 2005 | 39 | 0.060 |
Why?
|
| Self Disclosure | 1 | 2005 | 26 | 0.060 |
Why?
|
| Nonverbal Communication | 1 | 2004 | 5 | 0.060 |
Why?
|
| Crowding | 1 | 2024 | 11 | 0.060 |
Why?
|
| Gels | 1 | 2005 | 72 | 0.060 |
Why?
|
| Multivariate Analysis | 3 | 2014 | 1492 | 0.060 |
Why?
|
| Administration, Topical | 1 | 2005 | 143 | 0.060 |
Why?
|
| Health Status Indicators | 1 | 2005 | 130 | 0.060 |
Why?
|
| Age of Onset | 2 | 2010 | 637 | 0.060 |
Why?
|
| Office Visits | 1 | 2005 | 78 | 0.060 |
Why?
|
| Health Resources | 1 | 2005 | 127 | 0.050 |
Why?
|
| Videotape Recording | 1 | 2004 | 58 | 0.050 |
Why?
|
| Fatigue | 2 | 2018 | 201 | 0.050 |
Why?
|
| Cross-Over Studies | 1 | 2005 | 331 | 0.050 |
Why?
|
| Patient Health Questionnaire | 1 | 2023 | 18 | 0.050 |
Why?
|
| Critical Illness | 1 | 2008 | 629 | 0.050 |
Why?
|
| Kidney Neoplasms | 1 | 2008 | 462 | 0.050 |
Why?
|
| Analysis of Variance | 1 | 2005 | 1044 | 0.050 |
Why?
|
| Anticonvulsants | 2 | 1997 | 393 | 0.050 |
Why?
|
| Diffusion of Innovation | 1 | 2004 | 98 | 0.050 |
Why?
|
| Linear Models | 2 | 2011 | 723 | 0.050 |
Why?
|
| Hepacivirus | 1 | 2005 | 273 | 0.050 |
Why?
|
| Mental Recall | 2 | 2008 | 143 | 0.050 |
Why?
|
| Biomedical Research | 1 | 2008 | 556 | 0.050 |
Why?
|
| Drug Administration Schedule | 2 | 1994 | 756 | 0.050 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2010 | 872 | 0.050 |
Why?
|
| Statistics, Nonparametric | 1 | 2003 | 454 | 0.050 |
Why?
|
| Pregnancy | 1 | 2014 | 7570 | 0.050 |
Why?
|
| Stress, Physiological | 1 | 2004 | 272 | 0.050 |
Why?
|
| Pirenzepine | 1 | 2001 | 4 | 0.040 |
Why?
|
| Latin America | 1 | 2021 | 99 | 0.040 |
Why?
|
| Organizational Policy | 1 | 2001 | 54 | 0.040 |
Why?
|
| Prisoners | 1 | 2001 | 39 | 0.040 |
Why?
|
| Hypogonadism | 1 | 2005 | 319 | 0.040 |
Why?
|
| Life Change Events | 1 | 2001 | 65 | 0.040 |
Why?
|
| Goals | 1 | 2021 | 134 | 0.040 |
Why?
|
| Alcohol-Related Disorders | 1 | 2000 | 35 | 0.040 |
Why?
|
| Culture | 1 | 1999 | 73 | 0.040 |
Why?
|
| Negativism | 1 | 1999 | 2 | 0.040 |
Why?
|
| Concept Formation | 2 | 2009 | 27 | 0.040 |
Why?
|
| Reference Values | 3 | 2009 | 740 | 0.040 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2005 | 772 | 0.040 |
Why?
|
| Prefrontal Cortex | 1 | 2000 | 218 | 0.040 |
Why?
|
| Guidelines as Topic | 2 | 2010 | 203 | 0.040 |
Why?
|
| Evidence-Based Practice | 1 | 2019 | 116 | 0.040 |
Why?
|
| Virtual Reality | 1 | 2018 | 35 | 0.040 |
Why?
|
| Psychopathology | 1 | 1998 | 34 | 0.040 |
Why?
|
| Data Interpretation, Statistical | 2 | 2010 | 239 | 0.040 |
Why?
|
| Social Work | 1 | 1998 | 21 | 0.040 |
Why?
|
| Bioethics | 1 | 1999 | 74 | 0.040 |
Why?
|
| Clonazepam | 1 | 1997 | 5 | 0.030 |
Why?
|
| Diagnosis | 1 | 1997 | 30 | 0.030 |
Why?
|
| Social Values | 1 | 1997 | 48 | 0.030 |
Why?
|
| Evaluation Studies as Topic | 1 | 1997 | 261 | 0.030 |
Why?
|
| Movement | 1 | 2018 | 166 | 0.030 |
Why?
|
| Social Responsibility | 1 | 1997 | 83 | 0.030 |
Why?
|
| Postural Balance | 1 | 2018 | 132 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 1999 | 1740 | 0.030 |
Why?
|
| Electrodes | 1 | 2017 | 91 | 0.030 |
Why?
|
| Translating | 1 | 2017 | 31 | 0.030 |
Why?
|
| Ethics, Medical | 1 | 2000 | 401 | 0.030 |
Why?
|
| Proof of Concept Study | 1 | 2016 | 34 | 0.030 |
Why?
|
| Amnesia | 1 | 2016 | 18 | 0.030 |
Why?
|
| Single-Blind Method | 1 | 2017 | 250 | 0.030 |
Why?
|
| Fluoxetine | 1 | 1996 | 46 | 0.030 |
Why?
|
| Social Adjustment | 1 | 1996 | 79 | 0.030 |
Why?
|
| Choice Behavior | 1 | 1997 | 136 | 0.030 |
Why?
|
| Language | 1 | 2017 | 222 | 0.030 |
Why?
|
| Intention | 2 | 2009 | 97 | 0.030 |
Why?
|
| Safety | 2 | 2009 | 217 | 0.030 |
Why?
|
| Millon Clinical Multiaxial Inventory | 1 | 2013 | 2 | 0.030 |
Why?
|
| Organizational Culture | 1 | 2014 | 105 | 0.030 |
Why?
|
| Lithium | 1 | 1994 | 71 | 0.030 |
Why?
|
| MMPI | 1 | 2013 | 16 | 0.030 |
Why?
|
| Epilepsy, Temporal Lobe | 1 | 1995 | 91 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2017 | 1665 | 0.030 |
Why?
|
| Organ Transplantation | 1 | 1996 | 186 | 0.030 |
Why?
|
| Schizophrenic Psychology | 3 | 1999 | 85 | 0.030 |
Why?
|
| Triglycerides | 1 | 1996 | 617 | 0.030 |
Why?
|
| Cholesterol | 1 | 1996 | 574 | 0.030 |
Why?
|
| Drug Monitoring | 1 | 1994 | 183 | 0.030 |
Why?
|
| PubMed | 1 | 2013 | 23 | 0.030 |
Why?
|
| Leadership | 1 | 2014 | 243 | 0.020 |
Why?
|
| Volunteers | 1 | 2012 | 25 | 0.020 |
Why?
|
| Databases, Bibliographic | 1 | 2012 | 20 | 0.020 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 1994 | 252 | 0.020 |
Why?
|
| Housing | 1 | 2012 | 54 | 0.020 |
Why?
|
| Professional Autonomy | 1 | 2012 | 30 | 0.020 |
Why?
|
| Korean War | 1 | 2011 | 1 | 0.020 |
Why?
|
| World War II | 1 | 2011 | 6 | 0.020 |
Why?
|
| Salaries and Fringe Benefits | 1 | 2012 | 35 | 0.020 |
Why?
|
| Personal Satisfaction | 1 | 2012 | 106 | 0.020 |
Why?
|
| Clinical Protocols | 1 | 2012 | 245 | 0.020 |
Why?
|
| Social Class | 1 | 2012 | 210 | 0.020 |
Why?
|
| Workload | 1 | 2012 | 151 | 0.020 |
Why?
|
| Washington | 1 | 2010 | 35 | 0.020 |
Why?
|
| Interprofessional Relations | 1 | 2012 | 157 | 0.020 |
Why?
|
| House Calls | 1 | 2010 | 38 | 0.020 |
Why?
|
| Higher Nervous Activity | 1 | 2009 | 2 | 0.020 |
Why?
|
| Volition | 1 | 2009 | 11 | 0.020 |
Why?
|
| Deception | 1 | 2009 | 11 | 0.020 |
Why?
|
| Multicenter Studies as Topic | 1 | 2010 | 293 | 0.020 |
Why?
|
| Animals | 1 | 2011 | 36539 | 0.020 |
Why?
|
| Perception | 1 | 2010 | 237 | 0.020 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2010 | 152 | 0.020 |
Why?
|
| Motor Skills | 1 | 2009 | 85 | 0.020 |
Why?
|
| Eligibility Determination | 1 | 2008 | 38 | 0.020 |
Why?
|
| Hospital Mortality | 1 | 2013 | 1096 | 0.020 |
Why?
|
| Neurology | 1 | 2010 | 120 | 0.020 |
Why?
|
| Physician-Patient Relations | 1 | 2012 | 448 | 0.020 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2008 | 77 | 0.020 |
Why?
|
| Medically Uninsured | 1 | 2008 | 76 | 0.020 |
Why?
|
| Diagnostic Imaging | 1 | 2010 | 317 | 0.020 |
Why?
|
| Terminal Care | 1 | 2008 | 121 | 0.020 |
Why?
|
| Communication | 1 | 2011 | 542 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2009 | 1338 | 0.020 |
Why?
|
| Obsessive-Compulsive Disorder | 1 | 1994 | 828 | 0.010 |
Why?
|
| Recurrence | 1 | 2009 | 1472 | 0.010 |
Why?
|
| Reaction Time | 1 | 2005 | 170 | 0.010 |
Why?
|
| Demography | 1 | 2005 | 247 | 0.010 |
Why?
|
| Systems Integration | 1 | 2004 | 28 | 0.010 |
Why?
|
| Models, Theoretical | 1 | 2004 | 398 | 0.010 |
Why?
|
| Warfare | 1 | 2001 | 34 | 0.010 |
Why?
|
| Tomography, Emission-Computed | 1 | 2000 | 39 | 0.010 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2000 | 106 | 0.010 |
Why?
|
| Ethical Analysis | 1 | 2000 | 48 | 0.010 |
Why?
|
| Brief Psychiatric Rating Scale | 1 | 1999 | 7 | 0.010 |
Why?
|
| Cross-Cultural Comparison | 1 | 1999 | 59 | 0.010 |
Why?
|
| Estrogens | 1 | 2002 | 525 | 0.010 |
Why?
|
| Basal Ganglia Diseases | 1 | 1999 | 26 | 0.010 |
Why?
|
| Discriminant Analysis | 1 | 1998 | 26 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2010 | 3854 | 0.010 |
Why?
|
| Motivation | 1 | 2000 | 328 | 0.010 |
Why?
|
| Sleep Stages | 1 | 1997 | 33 | 0.010 |
Why?
|
| Flutamide | 1 | 1997 | 28 | 0.010 |
Why?
|
| Cerebrovascular Circulation | 1 | 2000 | 474 | 0.010 |
Why?
|
| Leuprolide | 1 | 1997 | 23 | 0.010 |
Why?
|
| Medical Indigency | 1 | 1997 | 3 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 1998 | 606 | 0.010 |
Why?
|
| Androgen Antagonists | 1 | 1997 | 134 | 0.010 |
Why?
|
| Education, Medical | 1 | 1999 | 302 | 0.010 |
Why?
|
| Temporal Lobe | 1 | 1995 | 118 | 0.010 |
Why?
|
| Memory | 1 | 1997 | 358 | 0.010 |
Why?
|
| Hypercholesterolemia | 1 | 1996 | 236 | 0.010 |
Why?
|
| Curriculum | 1 | 1999 | 764 | 0.010 |
Why?
|
| Electrocardiography | 1 | 1999 | 1005 | 0.010 |
Why?
|
| Electroencephalography | 1 | 1995 | 897 | 0.010 |
Why?
|